Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 148 clinical trials
Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Subcutaneous enoxaparin is currently the gold standard for VTE chemoprophylaxis. However, the efficacy of chemoprophylaxis with subcutaneous enoxaparin is affected by patient-level factors, thus, resulting in VTE events despite guideline-compliant prophylaxis. A population at particular risk is the growing number of patients who undergo autologous breast reconstruction. Direct oral anticoagulants …

enoxaparin 40mg/0.4ml prefilled syringe
anesthesia
anticoagulants
apixaban
apixaban 2.5 mg
  • 0 views
  • 26 Jan, 2021
  • 1 location
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

The Michelle trial is expected to provide high-quality evidence around the role of extended thromboprophylaxis in COVID-19 and will help guide medical decisions in clinical practice.

  • 0 views
  • 27 Jan, 2021
  • 1 location
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

venous thromboembolism among the study cohort will be calculated with an estimated 95% exact binomial confidence interval. A drop of greater than 20% (from 8% estimated in the historical control to 6.4

interval debulking surgery
cancer chemotherapy
aspirin
venous thromboembolism
cancer of the ovary
  • 0 views
  • 25 Jan, 2021
  • 1 location
STAT-STatin and Aspirin in Trauma

This is a phase II, pragmatic, prospective, randomized, double-blind, adaptive clinical trial examining the efficacy of statins and aspirin in the reduction of acute lung injury and venous

fibrinolysis
rosuvastatin
venous thromboembolism
aspirin
  • 27 views
  • 24 Jan, 2021
  • 1 location
Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

The pilot PARTUM trial is a randomized, multicenter, placebo-controlled trial. Women who are at modest risk of VTE (as defined by the inclusion criteria) will be identified during pregnancy, labor and delivery and up to 48 hours postpartum. Eligible and consenting participants will be randomly assigned to one of two …

deficiency
protein c
thrombophilia
clot
aspirin
  • 0 views
  • 26 Jan, 2021
  • 1 location
Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

To evaluate: - the incidence of venous thromboembolic event (VTE) - the incidence of hemorrhagic complications, In a population of patients with myeloma who are treated with IMiDs and require thromboprophylaxis for 6 months, using an oral anti-Xa anticoagulant, Apixaban, in a preventive scheme, 2.5 mg x2/day

melphalan
apixaban
dexamethasone
aspirin
lenalidomide
  • 45 views
  • 07 Nov, 2020
  • 14 locations
WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

-associated venous thromboembolism patients that weigh more than 90 kg.

pulmonary embolism
deep vein thrombosis
carcinoma
thrombosis
venous thromboembolism
  • 136 views
  • 02 Feb, 2021
  • 5 locations
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to rivaroxaban.

rivaroxaban
apixaban
anticoagulants
anticoagulation therapy
  • 210 views
  • 23 Jan, 2021
  • 2 locations
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

To evaluate the pharmacokinetics of the thromboprophylactic agent enoxaparin in postoperative cardiac surgery patients by comparing plasma anti-Xa activity when enoxaparin is administered either as a continuous intravenous infusion or subcutaneous bolus once daily. In the second part of the study with eleveted enoxaparin dosage, 4 additional blood samples will …

enoxaparin
  • 26 views
  • 03 Mar, 2021
  • 1 location
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

The objective of this study is to compare oral rivaroxaban with injectable enoxaparin in orthopaedic trauma patients to determine if orally administered rivaroxaban once daily carries greater compliance and overall satisfaction than enoxaparin self-administered by subcutaneous injection once daily.

venous thrombosis
deep vein thrombosis
thrombosis
thromboembolism prophylaxis
enoxaparin
  • 5 views
  • 23 Jan, 2021
  • 1 location